INTERNATIONAL STEM CELL CORPORATION — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$9M
Cost of Revenue
$4M
R&D
$684K
D&A
$219K
Operating Income
$-267K
EBITDA
$-48K
Interest Expense
$151K
Other Income/Expense
$0
Pretax Income
$-418K
Tax Provision
$0
Net Income
$-418K
Operating Margin
-2.9%
Net Margin
-4.6%
Effective Tax Rate
0.0%
Deferred Tax Assets
$90K
Deferred Tax Liabilities
$90K
DTA Valuation Allowance
$8M
Tax Credit Carryforwards
$922K
NOL Carryforwards
$5M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-10.6%
ETR Foreign Differential (pp)
-70.8%
Operating Lease Cost
$368K
Revenue YoY Variation
0.2%
Income YoY Variation
-292.6%